Trial intelligence / Profile preview

Impact of Duloxetine on Male Fertility

NCT03038867Phase 2Completed

Sponsor
Weill Cornell Medicine
Start
Dec 2016
Primary completion
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of duloxetine in major depressive disorder (MDD), sponsored by Weill Cornell Medicine. Started Dec 2016; status: completed.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT03038867.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03038867.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call